DescriptionSources: http://www.accessdata.fda.gov/spl/data/34edbae8-e952-4908-a425-b9f029bb4502/34edbae8-e952-4908-a425-b9f029bb4502.xmlCurator's Comment: Description was created based on several sources, including https://www.drugs.com/monograph/senna.html and http://www.drugbank.ca/drugs/DB11365
Sources: http://www.accessdata.fda.gov/spl/data/34edbae8-e952-4908-a425-b9f029bb4502/34edbae8-e952-4908-a425-b9f029bb4502.xml
Curator's Comment: Description was created based on several sources, including https://www.drugs.com/monograph/senna.html and http://www.drugbank.ca/drugs/DB11365
Sennosides are hydroxyanthracene glycosides derived from Senna leaves. They have been used as natural, safe time-tested laxatives in traditional as well as modern systems of medicine. Sennosides (Senna) is a medication used to treat constipation and empty the large intestine before surgery. The medication is taken by mouth or via the rectum. It typically begins working in minutes when given by rectum and within twelve hours when given by mouth. It is a weaker laxative than bisacodyl or castor oil. Senna is an FDA-approved nonprescription drug for adults and children ages 2 years and older. It is also used for bowel preparation before colonoscopy and diagnostic imaging.
Originator
Sources: https://www.drugs.com/npp/senna.html
Curator's Comment: Senna was first used medicinally by Arabian physicians in the 9th century A.D.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095173 Sources: http://www.ncbi.nlm.nih.gov/pubmed/11218732 |
680.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | SENNA Approved UseRelieves occasional constipation (irregularity) Launch Date1.35483844E12 |
Sample Use Guides
Adults and children 12 years of age or older - 2 tablets once a day starting dose; 4 tablets twice a day maximal dose; children 6 to under 12 years - 1 tablet once a day starting dose; 2 tablets twice a day maximal dose; each Senna Tablet contains: Sennosides 8.6 mg / Standardized Senna Concentrate
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/8010034
Sennosides (20 mmol/l) induced spontaneous spike potentials in guinea pig taenia coli.
Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Fri Dec 15 16:17:49 UTC 2023
by
admin
on
Fri Dec 15 16:17:49 UTC 2023
|
Source Materials Class | ORGANISM |
Source Materials Type | PLANT |
Source Materials Parent | |
Part | FRUIT; LEAF; STEM |
Fraction Name | ANTIOXIDANT ANTHROQUINONE GLUCOSIDE CALCIUM SALT |
Record UNII |
3FYP5M0IJX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
A06AB06
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
||
|
DSLD |
1162 (Number of products:8)
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
||
|
WHO-ATC |
A06AB56
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
||
|
NCI_THESAURUS |
C29697
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3FYP5M0IJX
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
PRIMARY | |||
|
3FYP5M0IJX
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
PRIMARY | |||
|
DB11365
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
PRIMARY | |||
|
1612007
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
PRIMARY | |||
|
CHEMBL2108559
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
PRIMARY | |||
|
36387
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
PRIMARY | RxNorm | ||
|
C29448
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
PRIMARY | |||
|
SUB40994
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
PRIMARY | |||
|
4307
Created by
admin on Fri Dec 15 16:17:49 UTC 2023 , Edited by admin on Fri Dec 15 16:17:49 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SUB_CONCEPT->SUBSTANCE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |